Huma Therapeutics has filed a patent for a system that estimates a subject’s level of interoception. The system includes a heartbeat sensor, user interface, and processor to receive information about the timing of heartbeats, create a periodic output, present it to the subject, and adjust the phase based on user input. GlobalData’s report on Huma Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Huma Therapeutics, Medical event scoring was a key innovation area identified from patents. Huma Therapeutics's grant share as of September 2023 was 43%. Grant share is based on the ratio of number of grants to total number of patents.
Estimating interoception level using heartbeat sensor and user interface
A recently filed patent (Publication Number: US20230255567A1) describes a system and method for estimating a subject's level of interoception. Interoception refers to the ability to perceive and understand internal bodily sensations. The system includes a heartbeat sensor that detects the subject's heartbeat, a user interface for receiving input from the subject, and a processor that performs various functions.
The processor receives information about the timing of the sensed heartbeats and uses this information to generate a periodic output with the same frequency as the heartbeats. This periodic output is then presented to the subject. The processor also receives input of a first type from the user interface, and based on this input, adjusts the phase at which the periodic output is presented to the subject.
Additionally, the processor can receive input of a second type from the user interface. In response to this input, it stores the current timing offset between the sensed heartbeats and the periodic elements of the periodic output. The processor can also determine a random offset from the sensed heartbeats and initially present the periodic output to the subject at a phase corresponding to this offset.
The periodic output can be in the form of a sound with periodic elements, such as tones. The user interface includes elements like a wheel and a button for the subject to interact with.
The processor can repeatedly perform the steps of receiving information, adjusting the phase, and storing timing offsets to form an estimate of the consistency of the stored timing offsets. This estimate can be used to assess the subject's level of interoception or even their identity.
In summary, the patent describes a system and method for estimating a subject's level of interoception by using a heartbeat sensor, a user interface, and a processor. The system generates a periodic output based on the timing of the subject's heartbeats and adjusts the phase of this output based on user input. The system can also store timing offsets and assess the consistency of these offsets to estimate the subject's level of interoception or identity.
To know more about GlobalData’s detailed insights on Huma Therapeutics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
